Of note, the lack of activation of the mTORC1/4E-BP1 axis by HBOT turns out to be advantageous, as many investigations related to cancer indicate that activation of the eIF4e axis can lead to tumorigenesis and tumor progression [2, 30, 31]. The gene discussed is EIF4E; the disease is cancer.